Uzunoğlu, F. G., Springfeld, C., Peccerella, T., Hank, T., Loos, M., Michalski, C., . . . Neoptolemos, J. P. (2026). Neoadjuvant therapy for left-sided resectable pancreatic ductal adenocarcinoma: Evidence-based shift or premature extrapolation? Hepatobiliary surgery and nutrition, 15(1), . https://doi.org/10.21037/hbsn-2025-587
Chicago Style (17th ed.) CitationUzunoğlu, Faik Güntaç, Christoph Springfeld, Teresa Peccerella, Thomas Hank, Martin Loos, Christoph Michalski, Thilo Hackert, and John P. Neoptolemos. "Neoadjuvant Therapy for Left-sided Resectable Pancreatic Ductal Adenocarcinoma: Evidence-based Shift or Premature Extrapolation?" Hepatobiliary Surgery and Nutrition 15, no. 1 (2026). https://doi.org/10.21037/hbsn-2025-587.
MLA (9th ed.) CitationUzunoğlu, Faik Güntaç, et al. "Neoadjuvant Therapy for Left-sided Resectable Pancreatic Ductal Adenocarcinoma: Evidence-based Shift or Premature Extrapolation?" Hepatobiliary Surgery and Nutrition, vol. 15, no. 1, 2026, https://doi.org/10.21037/hbsn-2025-587.